Complement-Based Drug Development Summit leaderboard
  • Monday, August 31, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 400

Author

Pharma Journalist 9027 posts 0 comments

Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access…

Apr 20, 2021
Citrine Medicine, a China-based rare disease therapeutics company, and Sinopharm Group, a Chinese pharmaceutical company, announced a strategic partnership to accelerate the…
Read More...

Registration is now open for Pre-filled Syringes San Francisco Conference 2021

Apr 20, 2021
SMi Reports: Registration has opened for the 2nd annual Pre-Filled Syringes San Francisco taking place on 13th – 14th September. As part of SMi’s leading Injectables series, this…
Read More...

FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab

Apr 19, 2021
The U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered…
Read More...

Top 10 Reasons to join SMi’s 4th Annual Pharmaceutical Microbiology West Coast Conference

Apr 16, 2021
SMi Group Reports: There are key top ten reasons to attend the 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference, taking on June 17th and 18th 2021. SMi Group are…
Read More...

GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the…

Apr 15, 2021
GSK and Vir continue discussions with global regulators to make VIR-7831 available to patients with COVID-19. GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the…
Read More...

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

Apr 15, 2021
Thermo Fisher Scientific Inc. and PPD, Inc. announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share…
Read More...

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel…

Apr 15, 2021
Alligator Bioscience announced that it has entered into a joint research collaboration with MacroGenics, Inc. a biopharmaceutical company focused on developing and commercializing…
Read More...

INOVIO’s COVID-19 Vaccine Candidate, INO-4800, Provides Broad Cross-reactive Immune Responses…

Apr 15, 2021
INOVIO a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, and cancer, announced the…
Read More...

Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin…

Apr 15, 2021
Arch Biopartners Inc. announced it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain (“Telara”) to clinically develop and market cilastatin, a…
Read More...

SciNeuro Pharmaceuticals Announces Exclusive Licensing Agreement with Eli Lilly & Company

Apr 15, 2021
SciNeuro Pharmaceuticals, an innovative biopharmaceutical company focused on delivering transformative therapies to patients with neurological diseases, has entered into an exclusive…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • FDA Approves Tivicay PD for Infants With HIV
  • FDA Grants Rare Pediatric Disease Designation to ReviR’s RTX-117
  • FDA Approves Ziihera Combinations for HER2-Positive GEA
  • FDA Approves RASONQUE for Metastatic Pancreatic Cancer
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.